RX
Recursion
RXRX·NASDAQSalt Lake City UTFounded 2013700 employees
Mid CapbiotechPublicOncologyRare DiseaseNeurology
Platform: AI Drug OS
Market Cap
$3.5B
All Drugs
3
Clinical Trials
6
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (RXRX)
Loading RXRX stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tixatapinarof | RXR-6874 | Approved | 3 | FGFR | Asthma | ||
| RXR-1394 | RXR-1394 | Phase 3 | 1 | BET | MesoBreast Ca | ||
| Terazumab | RXR-8243 | Phase 3 | 2 | AHR | MSHemophilia A |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)